{
  "id": 12658601,
  "title": "MustGrow Biologics at 20th iif: sales grow as Bayer backs pipeline",
  "url": "https://urgent.news/2026/10/07/mustgrow-biologics-at-20th-iif-sales-grow-as-bayer-backs-pipeline",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-07T15:45:53.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/mustgrow-biologics-at-20th-iif-sales-grow-as-bayer-backs-pipeline-93CH-4937172"
  },
  "original_language": "en",
  "account": "MustGrow Biologics Corp presented its growth story at the 20th International Investment Forum on October 7, 2026. The Canadian agricultural biotechnology company highlighted sales growth for its commercial biofertility product, TerraSante, which reached CAD 875,000 as of August 15, 2026, marking a 46% increase from 2025. The company sees significant market potential in natural crop inputs, with demand outpacing supply. However, MustGrow faces production and regulatory hurdles, including manufacturing constraints and the time required for regulatory approvals. Bayer is investing $35 million to $40 million in supporting TerraMG, a biopesticide that is already pre-registered and targets nematodes and disease. While the company's top-line growth is impressive, it remains unprofitable with a negative EBITDA of $3 million, but analysts consider it undervalued. MustGrow currently has 91 million fully diluted shares, CAD 4.3 million in cash, and debt of CAD 375,000, with total capital invested at about $30 million. The company's strategy includes developing natural alternatives to synthetic fertilizers and pesticides, using refined compounds from mustard seeds. TerraSante is OMRI certified and used in organic farming, while TerraMG is pre-registered with the U.S. Environmental Protection Agency and Canada’s Pest Management Regulatory Agency. The company targets high-value crops like strawberries, potatoes, leafy greens, and tomatoes for TerraSante and aims for a doubling of sales by the end of 2026.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}